A possible explanation for this resistance is offered by the copy number gain of FGF3 and FGF10 (Fig. 5A) in this cell line, both of which have previously been defined as resistance mechanisms to BYL719 in breast cancer [43]. Here, FGF3 is linked to breast cancer.